ArticleRisk management and healthcare policy2026
Medical Malpractice Compensation in China: A Retrospective Study of Litigation Cases From 2010 to 2015.
Article in Risk management and healthcare policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Medical negligence can cause patient harm and may result in malpractice lawsuits. This study examines compensation patterns in Chinese medical malpractice litigation from 2010 to 2015, the period between the 2010 Tort Liability Law and the 2018 Medical Disputes Regulation. Methods: We collected and analyzed 5052 closed first-trial medical malpractice litigation records in China. We provided descriptive characteristics of medical malpractice cases, including the medical specialty of the alleged cases, the severity of injury, the allegation of malpractice, and the geographic regions of cases. We also presented the aggregated amounts of monetary compensation. We then used a two-part model to examine the incremental compensation associated with characteristics of medical malpractice cases, and generated the adjusted predicted mean compensation. All monetary amounts were converted to 2022 Chinese Yuan (CNY). Results: Among all litigation records, the plaintiff received compensation in 4292 cases (85.0%). Cases involving death were significantly less likely to receive compensation and were awarded lower amounts (adjusted predicted mean: 177,374 CNY). In contrast, the severe-medium injury group received the highest adjusted predicted mean compensation compared to other injury groups (384,632 CNY). Pediatrics was associated with a significantly higher likelihood of compensation and higher compensation amounts compared to other medical specialties (adjusted predicted mean: 243,370 CNY). Delayed treatment and other adverse reactions were associated with significantly higher adjusted predicted mean compensation and ranked among the top three allegation types with the highest adjusted predicted mean compensation (176,111 CNY, 178,463 CNY, respectively), along with allergic reactions (189,746 CNY). Conclusion: This study advances methodological approaches for analyzing medical malpractice compensation in China. Our findings provide new directions for future research into how specific allegations and medical specialties relate to compensation and lay the groundwork for future research on the alignment between injury severity and legal outcomes in China's evolving medico-legal landscape.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.